细胞特异性转染实验方案
Note: Our new Invitrogen™ Lipofectamine™ Transfection Reagent Protocols have been newly optimized for efficiency, viability, and reproducibility across a broad range of cell types. This is often the best place to start, especially in a new cell line. If you find this doesn’t work for your specific cell type, then you can look to our cell-specific protocols below for further optimization.
| Cell Type | Source | Application | Recommended Invitrogen Transfection Reagent | Recommended Transfection SKU | Protocol/ Reference |
||
|---|---|---|---|---|---|---|---|
| 0 - 9 | |||||||
| 10T1/2 | Mouse embryonic fibroblast | Plasmid DNA | Lipofectamine™ 3000 | L3000008 | L3000015 | ||
| 293-F | Human kidney | Protein Production | 293fectin™ | 12347-019 | |||
| 293T | Human embryonic kidney | siRNA | Lipofectamine™ RNAiMAX | 13778-075 | 13778-150 | ||
| 3T3L1 | Mouse fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| 3T3L1 | Mouse fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| 786-O | Human renal cell adenocarcinoma cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| A-F | |||||||
| A549 | Human lung carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| A549 | Human lung carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| ACHN | Human renal cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| ARPE-19 | Human retina | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| B16-F10 | Mouse melanoma | Plasmid DNA | Lipofectamine | 18324-012 | 18324-020 | ||
| BAEC | Bovine aortic endothelial cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| BGOV-1 | Human embryonic stem cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| BHK-21 | Hamster kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Breast Adipose Fibroblasts | Human breast adipose | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| C2C12 | Mouse muscle myoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| C3A | Human hepatocellular Carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| C6 | Rat glioma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Caco-2 | Human colorectal adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Cardiac Fibroblasts | Adult rat heart | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| CaSki | Human cervical carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| CHO K1 | Hamster ovary | Plasmid DNA | Lipofectamine™ LTX | 15338-100 | 15338-500 | ||
| CHO-S | Hamster ovary | Protein Production | FreeStyle™ MAX Reagent | 16447-100 | 16447-500 | ||
| CMMT | Rhesus monkey mammary. tumor | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Cortical Neurons, E18 | Rat brain | Plasmid DNA | Lipofectamine LTX | 15338-100 | 15338-500 | ||
| COS 7L | Monkey kidney fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| COS 7L | Monkey kidney fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| CV-1 | Primate kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| CV-1 | Primate kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| D3 | Mouse embryonic stem cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| D3 | Mouse embryonic stem cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Daoy | Human medulloblastoma cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| DL-3 | Mouse T lymphoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| DLD-1 | Human colon adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| DT40 | Chicken Bursa | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| EOC | Human epithelial ovarian cancer | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Foreskin Fibroblast, Primary | Human foreskin | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| G - H | |||||||
| Glial Cell | Mouse brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| GripTite™ 293 MSR | Human kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HaCaT | Human immortalized keratinocytes | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HASMC | Human aortic smooth muscle cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HCT116 | Human colon carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HCT116 | Human colon carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HEK 293 | Human embryonic kidney | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HEK 293 | Human embryonic kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HEK 293 | Human embryonic kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HeLa S3 | Human cervical carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HeLa S3 | Human cervical carcinoma | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HeLa S3 | Human cervical carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Hepatocytes, Primary | Mouse liver | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HepG2 | Human liver carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HepG2 | Human liver carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Hippocampal Neurons | Rat brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Hippocampal Neurons | Rat brain | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HL60 | Human lymphoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HMEC-1 | Human dermal microvascular endothelial cells | Plasmid DNA | Lipofectamine LTX | 15338-100 | 15338-500 | ||
| HMVEC-L | Human lung microvascular endothelial cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HNSCC | Human head and neck squamous cell carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HT 29 | Human colon adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HT1080 | Human fibrosarcoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HT1080 | Human fibrosarcoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HT1376 | Human grade III transitional bladder cell carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Huh-7 | Human hepatocellular carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Huh-7 | Human hepatocellular carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Human Mesenchymal Stem Cells | Human bone marrow | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Human Mesenchymal Stem Cells | Human bone marrow | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| HUVEC | Human umbilical vein cord | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| HUVEC | Human umbilical vein cord | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| I - M | |||||||
| IMR-90 | Human embryonic lung | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| IMR-90 | Human embryonic lung | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| INS-1 | Rat pancreatic {beta}-cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| JEG-3 | Human choriocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Jurkat | Human T-cell leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| JygMC(A) | Mouse mammary carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| K562 | Human myelogenous leukemia | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| K562 | Human myelogenous leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| L929 | Mouse fibroblast cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| LC-NCI-H23 | Non-small cell, epid. | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| LNCap | Human prostate cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| LS180 | Human colon carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| LSMC | Human leiomyoma smooth muscle cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| M21 | Human melanoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| McA-RH7777 | Rat hepatoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MCF 7 | Human breast cancer | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MCF 7 | Human breast cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MCF 7 | Human breast cancer | Co-transfect Plasmid DNA and siRNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MDA-MB-231 | Human breast adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MDA-MB-435 | Human breast adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MDA-MB-435 | Human breast adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MDCK | Madin-Darby canine kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MDCK | Madin-Darby canine kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MDM | Human monocyte-derived macrophages | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| ME-180 | Human cervical carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MEF | Mouse embryonal fibroblast cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Mesangial Cells, Primary | Rat kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| mIMCD3 | Murine inner medullary collecting duct | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MIN6 | Mouse pancreatic {beta}-cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| MLT | Mouse Leydig tumor | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Molt-4 | Human T lymphoblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| MRC-5 | Human lung | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| N - R | |||||||
| N2a-APP | Mouse neuroblastoma N2a cells stably expressing human APP695 | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| N-38 | Mouse hypothalamic cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NB | Human neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NBS | Human Nijmegen breakage syndrome cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NCI-H460 | Human large cell lung cancer | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| NDHF | Neonatal dermal fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Neonatal Rat Ventricular Cardiomyocyte | Rat heart muscle | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| Neural Progenitor Cells, Primary | Embryonic mouse brain | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Neuro2A | Mouse brain neuroblastoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Neuro2A | Mouse brain neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NG108-15 | Hybrid of mouse neuroblastoma N18TG2 and rat glioma C6-BU-1 cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| NHFF | Human diploid somatic fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| NIH 3T3 | Mouse embryonic fibroblast | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| NIH 3T3 | Mouse embryonic fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NOR-10 (H-2b) | Mouse skeletal muscle cell line | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NRK | Rat normal kidney | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NT2 | Human teratocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| NTera2 | Human embryonic carcinoma stem cell | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| OLN-93, Primary | Rat brain glial cultures | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| OLP, Primary | Rat cerebra | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| P19 | Mouse embryonal carcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| P19 | Mouse embryonal carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| PC12 | Rat neuronal | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| PC3 | Human prostate adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Rat1 | Rat fibroblast cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| RAW264.7 | Mouse macrophage cells | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| RPC-C2A | Rat dental pulp cells | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| S - W | |||||||
| S2-013 | Human pancreas | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Saos-2 | Human osteosarcoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Sf9 | Insect ovary | DNA | Cellfectin™ | 10362-010 | |||
| SK-BR3 | Human breast carcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| SK-MEL-28 | Human malignant melanoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| SK-N-SH | Human neuroblastoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| SK-N-SH | Human neuroblastoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| SK-OV-3 | Human ovarian adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| SNB19 | Human glioblastoma cell line | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| SW1417 | Human colon adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| SW480 | Human colon adenocarcinoma | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| T47D | Human mammary adenocarcinoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| T98G | Human brain | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| THP-1 | Human monocytic leukemia | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| THP-1 | Human monocytic leukemia | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| U251 | Human glial | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| U2OS | Human osteosarcoma | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
| U87 | Human astrocyte | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| Vero | African green monkey kidney | Plasmid DNA | Lipofectamine 3000 | L3000008 | L3000015 | ||
| WI-38(VA13) | Normal human fetal lung fibroblast | siRNA | Lipofectamine RNAiMAX | 13778-075 | 13778-150 | ||
